CD95 ligand expression as a criterion of malignant transformation in breast cancer -: Reply

被引：0
|
作者：
Müllauer, L [1 ]
机构：
[1] Univ Vienna, Inst Clin Pathol, Vienna, Austria
来源：
JOURNAL OF PATHOLOGY | 2000年 / 191卷 / 04期
关键词：
D O I：
10.1002/1096-9896(200008)191:4<469::AID-PATH646>3.0.CO;2-L
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：469 / 470
页数：2
相关论文
共 50 条
  • [41] Inhibition of the alloantibody response by CD95 ligand
    Hiroshi Arai
    Sherri Y. Chanz
    D. Keith Bishop
    Gary J. Nabel
    Nature Medicine, 1997, 3 : 843 - 848
  • [42] CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BBLB/c mice
    Signore, A
    Annovazzi, A
    Procaccini, E
    Beales, PE
    Spencer, J
    Testi, R
    Ruberti, G
    DIABETOLOGIA, 1997, 40 (12) : 1476 - 1479
  • [43] CD95 expression and apoptosis during pediatric HIV infection: Early upregulation of CD95 expression
    McCloskey, TW
    Oyaizu, N
    Bakshi, S
    Kowalski, R
    Kohn, N
    Pahwa, S
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 87 (01): : 33 - 41
  • [44] CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BALB/c mice
    A. Signore
    A. Annovazzi
    E. Procaccini
    P. E. Beales
    J. Spencer
    R. Testi
    G. Ruberti
    Diabetologia, 1997, 40 : 1476 - 1479
  • [45] CD95/CD95 ligand-mediated counterattack does not block T cell cytotoxicity
    Jekle, A
    Obst, R
    Lang, F
    Rammensee, HG
    Gulbins, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 272 (02) : 395 - 399
  • [46] Mycobacterium tuberculosis exploits the CD95/CD95 ligand system of γδ T cells to cause apoptosis
    Manfredi, AA
    Heltai, S
    Rovere, P
    Sciorati, C
    Paolucci, C
    Gelati, G
    Rugarli, C
    Vaiani, R
    Clementi, E
    Ferrarini, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (06) : 1798 - 1806
  • [47] Differences between CD95 type I and type II cells detected with the CD95 ligand
    Schmitz, I
    Walczak, H
    Krammer, PH
    Peter, ME
    CELL DEATH AND DIFFERENTIATION, 1999, 6 (09): : 821 - 822
  • [48] The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis
    Manlio Tolomeo
    Luisa Dusonchet
    Maria Meli
    Stefania Grimaudo
    Natale D'Alessandro
    Giuliana Papoff
    Giovina Ruberti
    Luciano Rausa
    Cell Death & Differentiation, 1998, 5 : 735 - 742
  • [49] Evaluation of CD95 (APO-1/FAS) and the CD95 ligand in acute myelogenous leukemia
    Mestice, A
    Specchia, G
    Coppi, MR
    Palumbo, G
    Carluccio, P
    Attolico, I
    Quarta, A
    Liso, V
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 74 - 74
  • [50] The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis
    Tolomeo, M
    Dusonchet, L
    Meli, M
    Grimaudo, S
    D'Alessandro, N
    Papoff, G
    Ruberti, G
    Rausa, L
    CELL DEATH AND DIFFERENTIATION, 1998, 5 (09): : 735 - 742
12345